Dr. Stanley E. Skopit, DO

Dr. Skopit practices at Dermatology Group of Florida, P.A. in Dania, Florida.

Dr. Skopit's NPI, 1902865587, was assigned on March 21, 2006. Dr. Skopit graduated from Des Moines University in 1977. Dr. Skopit holds Florida license OS3893.

Dr. Skopit's primary practice is Dermatology Group of Florida, P.A., at 153 S Compass Way, Dania, FL 33004 in Broward County. The practice phone is (954) 807-9332.

Dr. Skopit's primary practice is Dermatology Group of Florida, P.A. in Dania, Florida. The medical group on file is Dermatology Group of Florida. Dmand AI also links Dr. Skopit to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Skopit practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Skopit's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Skopit is board certified in dermatology by the American Osteopathic Board of Dermatology. Dr. Skopit is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, hives and itchy rashes among the conditions Dr. Skopit treats.

CMS data shows 945 Medicare services from Dr. Skopit across 11 procedure codes in 2024, for 230 Medicare patients. Medicare paid $45,002 for them. Every service was in an office.

CMS counts 230 Medicare patients who saw Dr. Skopit in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Skopit's median patient age at 60, with 54% women.

In 2024, Dr. Skopit wrote 4,342 Medicare Part D claims for 1,248 patients. 90% of them were for generic drugs. CMS names the drug for 4,072 of them, across 40 drugs with 11 or more claims each, at $1,714,297 in total drug cost. In 2023, CMS named 4,388 claims across 45 drugs.

Dr. Skopit accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 179 procedures of removal of skin lesions by Dr. Skopit, more than 78% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 39 papers to Dr. Skopit, published from 2016 to 2025. 2016 was the busiest year, with 2. The most frequent topics are Dermatologic Agents, Down Syndrome and Keratosis. Dr. Skopit has published most often in J Drugs Dermatol. Dr. Skopit's most frequent co-authors are Laszlo J. Karai, MD, PhD, Andrew Allen Niemann, DO, MBA and Lauren Keegan Dozier, DO.

CMS Open Payments shows 737 general payments to Dr. Skopit from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $3,922.

Dmand AI lists 15 awards for Dr. Skopit, most recently AOCD Presidential Citation in 2010.

Dr. Skopit graduated from Des Moines University in 1977. Dr. Skopit is a member of AAD, AOA and ASDS.

Dr. Skopit is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.